우울증 스크리닝 AI 플랫폼 시장 예측(-2034년) - 스크리닝 방법별, 유통 모드별, 비즈니스 모델별, 기술 스택별, 최종사용자별, 지역별 분석

According to Stratistics MRC, the Global Depression-Screening AI Platforms Market is accounted for $0.8 billion in 2026 and is expected to reach $1.8 billion by 2034 growing at a CAGR of 10.0% during the forecast period. AI-based depression screening platforms apply machine learning and natural language processing to recognize early symptoms of depression from user interactions and digital behavior. They evaluate text inputs, speech tone, facial cues, and activity patterns to flag possible mental health concerns. These systems assist clinicians by providing initial assessments, streamlining screening processes, and supporting timely intervention. Commonly integrated into telemedicine services, hospitals, and employee wellness tools, they expand access to psychological evaluation. By making screening more private and user-friendly, they reduce stigma and increase engagement. Ongoing algorithm improvements enhance detection accuracy, strengthening their role in modern healthcare systems across global systems.

According to a bibliometric analysis of the Web of Science Core Collection (2015-2024), there were 2,304 publications on AI applications in depression diagnosis, reflecting rapid growth in academic and clinical interest in this field.

Market Dynamics:

Driver:

Rising prevalence of depression and mental health disorders

The expansion of the Depression-Screening AI Platforms Market is largely fueled by the rising incidence of depression and related psychological conditions worldwide. Modern lifestyle challenges, including high stress levels, isolation, and demanding work environments, have intensified mental health issues across populations. Many cases remain untreated due to social stigma and shortages of mental health professionals. AI-powered screening tools provide efficient, scalable, and early-stage detection of symptoms, enabling faster identification of at-risk individuals. This increasing mental health burden encourages healthcare providers to integrate digital solutions that support timely diagnosis, intervention, and improved overall psychological well-being.

Restraint:

Privacy and data security concerns

Concerns regarding privacy and protection of sensitive information significantly restrict the growth of the Depression-Screening AI Platforms Market. These systems handle confidential data such as emotional responses, behavioral patterns, and psychological history, making them vulnerable to misuse or cyberattacks. Any breach can result in serious issues including discrimination or emotional distress. Many users are reluctant to engage with these platforms due to fear of data exposure. Additionally, inconsistent international data protection regulations complicate compliance for developers. Ensuring strong encryption, secure data management, and ethical usage standards is essential but remains a key challenge hindering broader acceptance of these AI-driven screening tools.

Opportunity:

Expansion of digital mental health ecosystem

A key opportunity for the Depression-Screening AI Platforms Market lies in the fast-growing digital mental health ecosystem. The rising use of telehealth services, mental health applications, and virtual counseling platforms is creating a strong foundation for AI-based screening solutions. These technologies can be seamlessly incorporated into digital healthcare systems to enable early identification and ongoing tracking of depressive symptoms. Increased funding for mental health technology companies and expanding digital healthcare infrastructure are further driving growth. With healthcare increasingly focusing on prevention and remote care delivery, AI-driven screening tools are becoming essential components of future mental health management systems worldwide.

Threat:

Ethical concerns and algorithmic bias

A major threat to the Depression-Screening AI Platforms Market is the presence of ethical issues and algorithmic bias. Artificial intelligence models may unintentionally inherit biases from training datasets, leading to inconsistent or unfair mental health assessments across diverse population groups. This can increase the risk of misdiagnosis or unequal treatment outcomes. Ethical concerns also emerge due to limited transparency in AI decision-making and reduced human supervision in sensitive psychological evaluations. Questions regarding responsibility for incorrect predictions further impact trust. These challenges weaken confidence among clinicians and users, ultimately restricting the broader adoption of AI-driven depression screening solutions in healthcare systems.

Covid-19 Impact:

The COVID-19 pandemic positively influenced the Depression-Screening AI Platforms Market by speeding up the use of digital mental health technologies. Rising stress, isolation, unemployment, and uncertainty during the pandemic significantly increased depression rates worldwide, creating higher demand for remote screening solutions. With limited access to in-person healthcare services, telemedicine and AI-based platforms became essential for mental health evaluation. Healthcare providers rapidly adopted virtual care systems to ensure continuity of psychological support. Governments and institutions also expanded online mental health initiatives. This period emphasized the importance of accessible, scalable, and technology-driven screening tools in managing growing mental health concerns effectively across populations.

The digital self-assessment questionnaires segment is expected to be the largest during the forecast period

The digital self-assessment questionnaires segment is expected to account for the largest market share during the forecast period because they are easy to use, widely accessible, and simple to deploy across various digital healthcare channels. These questionnaires enable individuals to assess their mental health through structured digital forms available on mobile applications, websites, and clinical systems without requiring advanced technical setup. They are commonly accepted by healthcare providers for preliminary screening and identifying potential risks. Their affordability, scalability, and ability to serve large user bases contribute to their dominance. They also act as a basic input layer for AI-driven analysis, supporting early identification and intervention.

The individual consumers & patients segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the individual consumers & patients segment is predicted to witness the highest growth rate because of increasing mental health awareness, widespread smart phone usage, and strong demand for private self-guided digital screening tools. Users are actively adopting mobile apps and online platforms that allow confidential depression assessment without visiting healthcare facilities. Reduced stigma, improved accessibility, and user-friendly AI-based interfaces are further supporting growth. Integration with wearable technologies and personalized feedback systems enhances user engagement. Moreover, low cost and round-the-clock availability make these solutions highly attractive, driving rapid expansion of this consumer-focused segment over time period.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share because of its highly developed healthcare systems, strong digital health adoption, and concentration of major AI and mental health technology companies. Growing awareness of psychological disorders and government support for early mental health detection contribute to regional leadership. Widespread availability of telemedicine services and high usage of smartphones further enhance adoption rates. In addition, supportive insurance frameworks and reimbursement structures encourage healthcare providers to implement AI-based screening tools, making the region the most advanced and widely adopted market for such technologies.

Region with highest CAGR:

Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR because of rapid technological advancement, increasing awareness of mental health issues, and widespread growth in digital connectivity. Countries including India, China, Japan, and South Korea are actively enhancing their healthcare systems with AI-based innovations. A significant shortage of mental health professionals in the region is driving demand for accessible and cost-effective screening solutions. Government support for telemedicine and mental wellness initiatives is further boosting adoption. In addition, the expansion of health tech startups and rising use of mobile health apps are fueling strong market growth across Asia-Pacific.

Key players in the market

Some of the key players in Depression-Screening AI Platforms Market include Woebot Health, Wysa Ltd, Moodpath, Lyra Health, Inc., Spring Care, Inc. (Spring Health), Koa Health, Ellipsis Health, Cogito, Kintsugi Mindful Wellness, Inc., Limbic, AiCure, Cognito Therapeutics, Headspace Health, Aiberry, Sonde Health, Inc., X2AI, Mental Health AI and Calmerry.

Key Developments:

In February 2026, Wysa has secured GBP 5.3 Mn to adapt and evaluate an AI mental health tool for adolescent girls in rural India, in partnership with Imperial College London and Indian academic and community organisations. The collaboration, funded by Wellcome, focuses on scaling a clinically validated digital intervention designed to address anxiety and low mood in low-resource settings.

In November 2024, Cogito Capital Partners, a venture capital firm based in Warsaw and New York City, has announced the first close of its second fund, Cogito Fund II, targeting €125 million in total commitments. Cogito Capital Partners prioritize sectors where they can add value in crafting successful growth strategies. Key areas include enterprise software and data analytics, fintech and insurtech, and healthtech.

Screening Modalities Covered:

• Digital Self-Assessment Questionnaires
• AI-enabled Conversational Screening Tools
• Voice & Speech Pattern Analysis Platforms
• Facial Expression & Behavioral Analytics Systems
• Neurocognitive & Biomarker-based AI Diagnostics
• Multimodal Screening Platforms

Delivery Modes Covered:

• Mobile Application-based Screening Tools
• Web-based Screening Platforms
• Telehealth-integrated Screening Solutions
• In-clinic AI Screening Systems
• Workplace & Corporate Wellness Screening Programs

Business Models Covered:

• Subscription-based Digital Platforms
• One-time Purchase Screening Kits/Apps
• Institutional Licensing Models
• Hybrid (Freemium + Premium) Models

Technology Stacks Covered:

• Natural Language Processing (NLP) Engines
• Sentiment & Emotion Recognition Algorithms
• Machine Learning & Predictive Analytics Frameworks
• Integration with Electronic Health Records (EHR)
• Data Security & Privacy Compliance Modules

End Users Covered:

• Individual Consumers & Patients
• Clinicians & Therapists
• Hospitals & Healthcare Providers
• Educational Institutions
• Corporate Wellness Programs
• Research Centers

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Depression Screening AI Platforms Market, By Screening Modality

• 5.1 Digital Self-Assessment Questionnaires
• 5.2 AI-enabled Conversational Screening Tools
• 5.3 Voice & Speech Pattern Analysis Platforms
• 5.4 Facial Expression & Behavioral Analytics Systems
• 5.5 Neurocognitive & Biomarker-based AI Diagnostics
• 5.6 Multimodal Screening Platforms

6 Global Depression Screening AI Platforms Market, By Delivery Mode

• 6.1 Mobile Application-based Screening Tools
• 6.2 Web-based Screening Platforms
• 6.3 Telehealth-integrated Screening Solutions
• 6.4 In-clinic AI Screening Systems
• 6.5 Workplace & Corporate Wellness Screening Programs

7 Global Depression Screening AI Platforms Market, By Business Model

• 7.1 Subscription-based Digital Platforms
• 7.2 One-time Purchase Screening Kits/Apps
• 7.3 Institutional Licensing Models
• 7.4 Hybrid (Freemium + Premium) Models

8 Global Depression Screening AI Platforms Market, By Technology Stack

• 8.1 Natural Language Processing (NLP) Engines
• 8.2 Sentiment & Emotion Recognition Algorithms
• 8.3 Machine Learning & Predictive Analytics Frameworks
• 8.4 Integration with Electronic Health Records (EHR)
• 8.5 Data Security & Privacy Compliance Modules

9 Global Depression Screening AI Platforms Market, By End User

• 9.1 Individual Consumers & Patients
• 9.2 Clinicians & Therapists
• 9.3 Hospitals & Healthcare Providers
• 9.4 Educational Institutions
• 9.5 Corporate Wellness Programs
• 9.6 Research Centers

10 Global Depression Screening AI Platforms Market, By Geography

• 10.1 North America
  • 10.1.1 United States
  • 10.1.2 Canada
  • 10.1.3 Mexico
• 10.2 Europe
  • 10.2.1 United Kingdom
  • 10.2.2 Germany
  • 10.2.3 France
  • 10.2.4 Italy
  • 10.2.5 Spain
  • 10.2.6 Netherlands
  • 10.2.7 Belgium
  • 10.2.8 Sweden
  • 10.2.9 Switzerland
  • 10.2.10 Poland
  • 10.2.11 Rest of Europe
• 10.3 Asia Pacific
  • 10.3.1 China
  • 10.3.2 Japan
  • 10.3.3 India
  • 10.3.4 South Korea
  • 10.3.5 Australia
  • 10.3.6 Indonesia
  • 10.3.7 Thailand
  • 10.3.8 Malaysia
  • 10.3.9 Singapore
  • 10.3.10 Vietnam
  • 10.3.11 Rest of Asia Pacific
• 10.4 South America
  • 10.4.1 Brazil
  • 10.4.2 Argentina
  • 10.4.3 Colombia
  • 10.4.4 Chile
  • 10.4.5 Peru
  • 10.4.6 Rest of South America
• 10.5 Rest of the World (RoW)
  • 10.5.1 Middle East
    • 10.5.1.1 Saudi Arabia
    • 10.5.1.2 United Arab Emirates
    • 10.5.1.3 Qatar
    • 10.5.1.4 Israel
    • 10.5.1.5 Rest of Middle East
  • 10.5.2 Africa
    • 10.5.2.1 South Africa
    • 10.5.2.2 Egypt
    • 10.5.2.3 Morocco
    • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

• 11.1 Industry Value Network and Supply Chain Assessment
• 11.2 White-Space and Opportunity Mapping
• 11.3 Product Evolution and Market Life Cycle Analysis
• 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

• 12.1 Mergers and Acquisitions
• 12.2 Partnerships, Alliances, and Joint Ventures
• 12.3 New Product Launches and Certifications
• 12.4 Capacity Expansion and Investments
• 12.5 Other Strategic Initiatives

13 Company Profiles

• 13.1 Woebot Health
• 13.2 Wysa Ltd
• 13.3 Moodpath
• 13.4 Lyra Health, Inc.
• 13.5 Spring Care, Inc. (Spring Health)
• 13.6 Koa Health
• 13.7 Ellipsis Health
• 13.8 Cogito
• 13.9 Kintsugi Mindful Wellness, Inc.
• 13.10 Limbic
• 13.11 AiCure
• 13.12 Cognito Therapeutics
• 13.13 Headspace Health
• 13.14 Aiberry
• 13.15 Sonde Health, Inc.
• 13.16 X2AI
• 13.17 Mental Health AI
• 13.18 Calmerry